A. K. Buck, K. Herrmann, T. Stargardt, T. Dechow, B. J. Krause and J. Schrey?gg, “Economic Evaluation of PET and PET/CT in Oncology: Evidence and Methodologic Approaches,” Journal of Nuclear Medicine, Vol. 51, No. 3, 2010, pp. 401-412. Hdoi:10.2967/jnumed.108.059584
 M. W. Saif, I. Tzannou, N. Makrilia and K. Syrigos, “Role and Cost Effectiveness of PET/CT in Management of Patients with Cancer,” Yale Journal of Biology and Medicine, Vol. 83, No. 2, 2010, pp. 53-65.
 A. Orlacchio, O. Schillaci, E. Gaspari, F. Della Gatta, R. Danieli, F. Bolacchi, C. Ragano Caracciolo, A. Mancini and G. Simonetti, “Role of [18F]-FDG-PET/MDCT in Evaluating Early Response in Patients with Hodgkin ’s Lymphoma,” La Radiologia Medica, Vol. 117, No. 7, 2012, pp. 1250-1263. Hdoi:10.1007/s11547-012-0792-8
 B. Krug, A. S. Pirson, R. Crott and T. Vander Borght, “Is a Methodology Available That Accurately Measures the Cost of an FDG-PET Study?” European Journal of Nuclear Medicine and Molecular Imaging, Vol. 34, No. 5, 2007, pp. 625-657. Hdoi:10.1007/s00259-006-0308-y
 R. Remonnay, M. Morelle, P. Pommier, F. Giammarile and M. O. Carrere, “Assessing Short Term Effects and Costs at an Early Stage of Innovation: The Use of Positron Emission Tomography on Radiotherapy Treatment Decision Making,” International Journal of Technology Assessment in Health Care, Vol. 24, No. 2, 2008, pp. 212220. Hdoi:10.1017/S026646230808029X